Morbid Obesity and Thyroid Cancer Rate. A Review of Literature.
adipokines
chronic inflammation
obesity
thyroid cancer
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
27 Apr 2021
27 Apr 2021
Historique:
received:
25
03
2021
revised:
23
04
2021
accepted:
25
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
In the past three decades, several recent studies have analyzed the alarming increase of obesity worldwide, and it has been well established that the risk of many types of malignancies is increased in obese individuals; in the same period, thyroid cancer has become the fastest growing cancer of all malignancies. We investigated the current literature to underline the presence of a connection between excess body weight or Body Mass Index (BMI) and risk of thyroid cancer. Previous studies stated that the contraposition between adipocytes and adipose-resident immune cells enhances immune cell production of multiple pro-inflammatory factors with subsequent induction of hyperlipidemia and vascular injury; these factors are all associated with oxidative stress and cancer development and/or progression. Moreover, recent studies made clear the mitogenic and tumorigenic action of insulin, carried out through the stimulation of mitogen-activated protein kinase (MAPK) and phosphoinositide-3 kinase/AKT (PI3K/AKT) pathways, which is correlated to the hyperinsulinemia and hyperglycemia found in obese population. Our findings suggest that obesity and excess body weight are related to an increased risk of thyroid cancer and that the mechanisms that combine overweight with this cancer should be searched for in the adipokine pathways and chronic inflammation onset.
Identifiants
pubmed: 33925549
pii: jcm10091894
doi: 10.3390/jcm10091894
pmc: PMC8123763
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Thyroid. 2014 Feb;24(2):190-9
pubmed: 23879222
Endocr Relat Cancer. 2011 Jul 04;18(4):R125-47
pubmed: 21606157
Am J Epidemiol. 2007 Nov 15;166(10):1140-9
pubmed: 17855390
J Thyroid Res. 2011;2011:832163
pubmed: 22007338
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
Trends Pharmacol Sci. 2005 Feb;26(2):69-76
pubmed: 15681023
Obes Facts. 2009;2(2):117-25
pubmed: 20054215
Mol Cell Endocrinol. 2010 May 28;321(1):94-102
pubmed: 19835928
Int J Biol Sci. 2011;7(7):1003-15
pubmed: 21912508
Ann Surg. 2019 Jan;269(1):95-101
pubmed: 28938270
Medicine (Baltimore). 2016 Mar;95(9):e2825
pubmed: 26945364
Nat Rev Cancer. 2008 Dec;8(12):915-28
pubmed: 19029956
Ann Oncol. 2014 Oct;25(10):1901-1914
pubmed: 24769692
Eur Thyroid J. 2016 Jul;5(2):125-31
pubmed: 27493887
Endocr Relat Cancer. 2008 Dec;15(4):1069-74
pubmed: 18719091
Am J Physiol. 1998 Jan;274(1):R204-8
pubmed: 9458919
Physiol Rev. 2009 Jul;89(3):1025-78
pubmed: 19584320
Oncogene. 2000 May 15;19(21):2474-88
pubmed: 10851046
Gastroenterology. 2021 Mar 18;:
pubmed: 33744305
Lancet. 2008 Feb 16;371(9612):569-78
pubmed: 18280327
Oncogene. 2003 Jan 16;22(2):246-55
pubmed: 12527893
Cancer Epidemiol Biomarkers Prev. 2017 Oct;26(10):1519-1524
pubmed: 28698186
Obes Rev. 2015 Dec;16(12):1042-54
pubmed: 26365757
Cancer Cell. 2012 Mar 20;21(3):309-22
pubmed: 22439926
J Clin Oncol. 2008 Jul 10;26(20):3395-402
pubmed: 18612154
Trends Mol Med. 2012 Jan;18(1):59-68
pubmed: 21889406
BMC Surg. 2020 Nov 7;20(1):275
pubmed: 33160350
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Endocr Relat Cancer. 2016 Jan;23(1):53-63
pubmed: 26552408
Med Sci Monit. 2015 Jan 22;21:283-91
pubmed: 25612155
Clin Endocrinol (Oxf). 2004 Oct;61(4):405-13
pubmed: 15473869
Thyroid. 2014 Jun;24(6):987-93
pubmed: 24483833
Annu Rev Pathol. 2016 May 23;11:421-49
pubmed: 27193454
Lancet. 2016 Apr 2;387(10026):1377-1396
pubmed: 27115820
Nutr Metab Cardiovasc Dis. 2018 May;28(5):436-443
pubmed: 29609864
J Clin Endocrinol Metab. 2011 Mar;96(3):766-74
pubmed: 21123448
Nat Rev Endocrinol. 2011 Aug 30;7(10):569-80
pubmed: 21878896
Int J Cancer. 2018 Apr 1;142(7):1332-1342
pubmed: 29168186
Physiol Rev. 2015 Jul;95(3):727-48
pubmed: 26084689
Annu Rev Physiol. 2010;72:219-46
pubmed: 20148674
PeerJ. 2020 Sep 8;8:e9675
pubmed: 33194342
J Clin Endocrinol Metab. 2011 Dec;96(12):E2023-8
pubmed: 21937620
Curr Opin Pharmacol. 2016 Aug;29:77-89
pubmed: 27429211
Endocr Relat Cancer. 2010 Feb 18;17(1):191-202
pubmed: 20008098
Lancet. 2001 Feb 17;357(9255):539-45
pubmed: 11229684
Cancers (Basel). 2021 Mar 25;13(7):
pubmed: 33805984
Endocrinology. 2013 Aug;154(8):2936-47
pubmed: 23748362
Horm Cancer. 2018 Apr;9(2):108-116
pubmed: 29352404
Protein Cell. 2014 Jan;5(1):12-20
pubmed: 24474192
Cell Biochem Biophys. 2013 Mar;65(2):203-10
pubmed: 22907586
Trends Genet. 2001 Oct;17(10):580-9
pubmed: 11585664
J Int Med Res. 2012;40(6):2041-50
pubmed: 23321160
J Clin Endocrinol Metab. 2001 May;86(5):1930-5
pubmed: 11344187
Metabolism. 2019 Mar;92:121-135
pubmed: 30445141
ISRN Oncol. 2012;2012:982769
pubmed: 23213569
J Obes. 2015;2015:343479
pubmed: 26347815
Horm Metab Res. 2016 Dec;48(12):787-794
pubmed: 27923249
Eur J Cancer. 2013 Apr;49(6):1374-403
pubmed: 23485231
J Clin Endocrinol Metab. 2015 Jan;100(1):184-92
pubmed: 25368977
J Clin Endocrinol Metab. 2010 Aug;95(8):3614-7
pubmed: 20685890
Lancet. 2016 Dec 3;388(10061):2783-2795
pubmed: 27240885
Surgery. 2011 Nov;150(5):950-8
pubmed: 21621238
Lancet. 2011 Aug 27;378(9793):804-14
pubmed: 21872749
Cancer Res. 2008 Mar 1;68(5):1407-16
pubmed: 18316604
CA Cancer J Clin. 2013 Jan;63(1):11-30
pubmed: 23335087
Endocr Pathol. 1997 Autumn;8(3):225-230
pubmed: 12114726
Cell. 2014 Jan 16;156(1-2):20-44
pubmed: 24439368
Thyroid. 2016 May;26(5):657-66
pubmed: 26959390
Cancer Biol Med. 2012 Dec;9(4):213-20
pubmed: 23691481